H.C. Wainwright’s $130 target on RYTM

RYTM Rhythm Pharmaceuticals Inc

$90.8 → $130 (+43%) by Oct 2027

Buy · raises · said Oct 12, 2026 · 12-month default horizon

Open: judged on the close on Oct 12, 2027

The article this target came from

H.C. Wainwright raises Rhythm Pharmaceuticals stock price target to $130 on Japan approval

Investing.com · Oct 12, 2026

H.C. Wainwright raised its price target on Rhythm Pharmaceuticals stock (NASDAQ:RYTM) to $130 from $105

H.C. Wainwright’s track record → Rhythm Pharmaceuticals Inc →

A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.